Answers are grounded in this paper and cite their sources.
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by persistent difficulties in social communication and interaction, along with restricted and repetitive patterns of behaviour. Emerging evidence suggests that alterations in the gut microbiota and their metabolic activity may contribute to the pathophysiology of ASD through interactions involving the gut–brain axis. Among the various microbiota-derived metabolites, p-cresol, p-cresyl sulfate, and indoxyl sulfate have attracted increasing attention because of their potential neuroactive properties, associations with intestinal microbial composition, and possible implications for neurodevelopment and behavioural functioning. This systematic review and meta-analysis aims to comprehensively evaluate and quantitatively synthesize the available evidence on urinary concentrations of p-cresol, p-cresyl sulfate, and indoxyl sulfate in children with ASD compared with typically developing children or other relevant control populations. The study will systematically identify, critically appraise, and synthesize observational studies reporting urinary concentrations of these metabolites, with the primary objective of determining whether their levels differ significantly between children with ASD and controls. Secondary objectives include evaluating metabolite-specific differences, exploring potential sources of heterogeneity across studies, and examining associations between metabolite concentrations and clinical or demographic characteristics, including age, sex, ASD severity, gastrointestinal symptoms, and relevant analytical and methodological factors, where data are available. A systematic search will be conducted across relevant electronic databases, and eligible studies will be selected according to predefined inclusion and exclusion criteria. Quantitative synthesis will be performed using appropriate meta-analytic methods, with effect estimates and 95% confidence intervals calculated according to the reported data and measurement characteristics. Heterogeneity will be assessed using statistical measures, and subgroup analyses, sensitivity analyses, and meta-regression will be considered where sufficient data are available. The methodological quality and certainty of evidence will also be evaluated using appropriate assessment frameworks. The anticipated outcome of this review is to clarify whether urinary microbiota-derived metabolites represent reproducible biochemical differences in children with ASD and to assess their potential relevance as candidate biomarkers. By synthesizing the existing evidence, this study may contribute to a better understanding of microbiota-related metabolic alterations in ASD, identify important research gaps, and inform future investigations into the gut–brain axis, metabolic profiling, and potential diagnostic or therapeutic applications. The findings will be interpreted cautiously, considering the observational nature of the available evidence and the potential influence of confounding factors.
No takes yet. Share an insight, caveat, or question.
Preethi (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: